Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes

Yaoxue Xuebao

Volumn 45, Issue 6, 2010, Pages 677-683

  Xu, Huan ^a   Wang, Kai Qian ^b   Huang, Wei Wei ^b   Deng, Yi Hui ^b   Chen, Da Wei ^b  

^a LIAONING NORMAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Accelerated blood clearance; Anti Polyethylene glycol IgM; Liposome; Polyethylene glycol

Indexed keywords

LIPOSOME; MACROGOL; NANOCARRIER; PEGYLATED LIPOSOME; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ACCELERATED BLOOD CLEARANCE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG FORMULATION; ISOTOPE LABELING; LIVER; MONONUCLEAR PHAGOCYTE; NONHUMAN; PLASMA CLEARANCE; REVIEW; SPLEEN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG CARRIERS; IMMUNOGLOBULIN M; LIPOSOMES; LIVER; METABOLIC CLEARANCE RATE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SERUM ALBUMIN, BOVINE; SPLEEN;

EID: 77956861775     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Dams ETM, Laverman P, Oyen WJG, et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes [J]. J Pharmacol Exp Ther, 2000,292:1071-1079.
2. Laverman P, Carstens MG, Boerman OC, et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection [J]. J Pharmacol Exp Ther, 2001, 298: 607-612.
3. Ishida T, Atobe K, Wang XY, et al. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin- encapsulation and high-dose first injection [J]. J Control Release, 2006, 115: 251-258.
4. Semple SC, Harasym TO, Clow KA, et al. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid [J]. J Pharmacol Exp Ther, 2005, 312: 1020-1026.
5. Ishida T, Masuda K, Ichikawa T, et al. Accelerated clearance of a second injection of PEGylated liposomes in mice [J]. Int J Pharm, 2003, 255: 167-174. (Pubitemid 36369600)
6. Ishida T, Harada M, Wang XY, et al. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes [J]. J Control Release, 2005, 105: 305-317.
7. Ishida T, Maeda R, Ichihara M, et al. Accelerated clearance of PEGylated liposomes in rats after repeated injections [J]. J Control Release, 2003, 88: 35-42. (Pubitemid 36173950)
8. Ishida T, Kashima S, Kiwada H. The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats [J]. J Control Release, 2008, 126: 162-165.
9. Parr MJ, Ansell SM, Choi LS, et al. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles [J]. Biochim Biophys Acta, 1994, 1195: 21-30.
10. Silvius JR, Zuckermann MJ. Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion [J]. Biochemistry, 1993, 32: 3153-3161.
11. Ishida T, Ichihara M, Wang XY, et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes [J]. J Control Release, 2006, 112: 15-25.
12. Ishida T, Ichihara M, Wang XY, et al. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes [J]. J Control Release, 2006, 115: 243-250.
13. Ishida T, Kiwada H. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes [J]. Int J Pharm, 2008, 354: 56-62.
14. Judge A, McClintock K, Phelps JR, et al. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes [J]. Mol Ther, 2006, 13: 328-337.
15. Milner EC, Anolik J, Cappione A, et al. Human innate B cells: a link between host defense and autoimmunity? [J]. Springer Semin Immuno Pathol, 2005, 26: 433-452.
16. Mizoguchi A, Bhan AK. A case for regulatory B cells [J]. J Immunol, 2006, 176: 705-710.
17. Wang XY, Ishida T, Kiwada H. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes [J]. J Control Release, 2007, 119: 236-244.
18. Ishida T, Ichikawa T, Ichihara M, et al. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice [J]. J Control Release, 2004, 95: 403-412.
19. Wang XY, Ishida T, Ichihara M, et al. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats [J]. J Control Release, 2005, 104: 91-102.
20. Tagami T, Nakamura K, Shimizu T, et al. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production [J]. J Control Release, 2009, 137: 234-240.
21. Goins B, Philips WT, Klipper R. Repeat injection studies of technetium-99m-labeled PEG-liposomes in the same animal [J]. J Liposome Res, 1998, 8: 265-281.
22. Oussoren C, Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol) [J]. Pharm Res, 1997, 14: 1479-1484.
23. Oussoren C, Storm G Effect of repeated intravenous administration on circulation kinetics of poly(ethyleneglycol)-liposomes in rats [J]. J Liposome Res, 1999, 9: 349-355.
24. Lu W, Wan J, She ZJ, et al. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle [J]. J Control Release, 2007, 118: 38-53.
25. Ishihara T, Takeda M, Sakamoto H, et al. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles [J]. Pharm Res, 2009, 26: 2270-2279.